This is a Validated Antibody Database (VAD) review about human sodium iodide symporter, based on 4 published articles (read how Labome selects the articles), using sodium iodide symporter antibody in all methods. It is aimed to help Labome visitors find the most suited sodium iodide symporter antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
sodium iodide symporter synonym: NIS; TDH1; sodium/iodide cotransporter; Na(+)/I(-) cotransporter; Na(+)/I(-) symporter; solute carrier family 5 (sodium iodide symporter), member 5; solute carrier family 5 (sodium/iodide cotransporter), member 5
Invitrogen
mouse monoclonal (FP5A) |
| In order to study the relationship between sodium/iodide symporter expression and human breast cancer cell lines with different sensitivity to doxorubicin, Invitrogen sodium iodide symporter antibody (Thermo Scientific, FP5A) was used in immunocytochemistry on human samples at 1:150 (fig 2). Exp Oncol (2016) ncbi |
mouse monoclonal (FP5A) |
| In order to discuss methods to treat retinoblastoma, Invitrogen sodium iodide symporter antibody (Thermofisher, MA5-12308) was used in western blot on human samples at 1:450 (fig 2g). Exp Eye Res (2015) ncbi |
mouse monoclonal (FP5A) |
| In order to assess gene activation under various hypoxic conditions in vivo., Invitrogen sodium iodide symporter antibody (Lab Vision, FP5A) was used in immunohistochemistry - paraffin section on human samples (fig 6). Ann Nucl Med (2014) ncbi |
Abcam
rabbit polyclonal |
| In order to evaluate the use of RNA activation-mediated upregulation of the sodium/iodide symporter to treat hepatocellular carcinoma, Abcam sodium iodide symporter antibody (Abcam, ab83816) was used in immunohistochemistry on human samples at 1:200 (fig 2e) and in western blot on human samples at 1:500 (fig 2b). Cancer Gene Ther (2016) ncbi |
Articles Reviewed
- Lukianova N, Andriiv A, Chekhun V. Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin. Exp Oncol. 2016;38:169-71 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
related gene review
questions and comments